Background: The association between atopic dermatitis (AD) and contact allergy, remains unclear, with studies to date showing conflicting results.
Objectives: To investigate the prevalence of contact allergy in AD individuals compared to those without AD.
Methods: Results of 46 250 patients patch tested in a single centre over a span of 30 years were reviewed, comparing those with AD with those without AD. Collected data were analysed with corrections for multiple confounding variables, including date of patch testing to account for changes in allergens tested over the period.
Results: Nine allergens showed a statistically significant difference between the two groups. Contact allergy to nickel, cobalt and primin was less likely to arise in those with AD, whilst substances found in topical dermatological products were more likely to be associated with AD.
Conclusions: This is the largest single centre study of contact sensitization in atopy reported to date. The previously reported association between contact allergy to sesquiterpene lactone and AD is reinforced. The decreased incidence of metal allergy suggests distinct immunological effector mechanisms in sensitization to these allergens. In keeping with previous publications, exposure to topical treatments for AD can result in sensitisation and contact allergy and clinicians should consider patch testing in AD individuals who report worsening of their skin despite continued treatment with topical medicaments.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/cod.13363 | DOI Listing |
Dermatol Ther (Heidelb)
January 2025
Burkhart Pediatric and Adolescent Dermatology, Cary, NC, USA.
Objectives: Allergic contact dermatitis occurs frequently in children. The proportion of children of color in the US is increasing, and racial and ethnic minority representation is important in pediatric allergic contact dermatitis research. The objectives of our study were to identify differences in age, sex, race and ethnicity among pediatric patch tests obtained from 2017 to 2022.
View Article and Find Full Text PDFContact Dermatitis
January 2025
Private Practice, Paris, France.
Contact Dermatitis
January 2025
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Pulm Ther
January 2025
US Medical Affairs, GSK, ATC Fowler Building, 410 Blackwell Street, Durham, NC, 27701, USA.
Introduction: Escalation to single- or multiple-inhaler triple therapy (SITT; MITT) is a recommended option for patients with asthma who remain uncontrolled by medium-dose inhaled corticosteroid/long-acting β-agonist; however, characterization of elderly users of triple therapy is limited. This real-world cohort study describes demographics and clinical characteristics of elderly patients with asthma with and without comorbid chronic obstructive pulmonary disease (COPD) who are new users of triple therapy, and asthma treatment patterns preceding triple therapy initiation.
Methods: This retrospective cohort study used administrative claims data from the Optum Clinformatics Data Mart database.
Contact Dermatitis
January 2025
Department of Dermatology and Venereology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Türkiye.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!